ERLOTINIB TARO 100 MG 30 TAB

Description

ERLOTINIB (Taro) 100 mg is an epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor used in the treatment of metastatic non-small cell lung cancer (NSCLC) and pancreatic cancer. It blocks EGFR signaling to inhibit tumor growth.